Skip to main content Skip to main content
LLY · USPTO Filings

Eli Lilly and Company — Patent Applications


Recent USPTO patent applications filed under applicant “Eli Lilly and Company / ELI LILLY AND COMPANY” — pending requests, not granted patents. Where a filing continues an already-granted parent, the parent’s number is shown.

50
Tracked Applications
6
Continuations of Granted Parents

Recent Applications

Every row is a patent application — a pending request, not a granted patent. “Granted Parent” shows the parent patent number when a filing continues an already-granted family. Newest filings first. Source: USPTO Open Data Portal (public).

TitleFiledApplication #StatusGranted Parent
MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM2026-01-1619450968Docketed New Case - Ready for Examination
METHODS AND APPARATUS FOR DETERMINING DEVICE DOSAGE2025-11-2619401661Docketed New Case - Ready for Examinationparent 12505906
PLUNGER DRIVE SYSTEM FOR A MEDICATION DELIVERY DEVICE2025-11-25PCTUS2025056968RO PROCESSING COMPLETED-PLACED IN STORAGE
ATXN2 RNA INTERFERENCE AGENTS2025-11-21PCTUS2025056497PCT - International Search Report Mailed to IB
AMPK-BETA-1-ACTIVATING COMPOUNDS AND METHODS OF USING THE SAME2025-11-19PCTUS2025056071RO PROCESSING COMPLETED-PLACED IN STORAGE
METHODS OF USING AND COMPOSITIONS INCLUDING AN INCRETIN ANALOG2025-11-1819393199Docketed New Case - Ready for Examinationparent 12496329
SUBSTITUTED HETEROARYL-HETEROARYL GLUCAGON RECEPTOR AGONISTS AND THEIR USE AS THERAPIES2025-11-18PCTUS2025055851RO PROCESSING COMPLETED-PLACED IN STORAGE
METHODS OF USING AND COMPOSITIONS INCLUDING AN INCRETIN ANALOG2025-11-1819393216Docketed New Case - Ready for Examinationparent 12496329
ALK7 RNA INTERFERENCE AGENTS2025-11-17PCTUS2025055788RO PROCESSING COMPLETED-PLACED IN STORAGE
PLIN1 RNA INTERFERENCE AGENTS2025-11-17PCTUS2025055782RO PROCESSING COMPLETED-PLACED IN STORAGE
PLIN1 RNAi INTERFERENCE AGENTS2025-11-1719391737Docketed New Case - Ready for Examination
ORAL COMPOSITIONS COMPRISING LP(A) INHIBITOR COMPOUNDS2025-11-13PCTUS2025055302RO PROCESSING COMPLETED-PLACED IN STORAGE
ORAL COMPOSITIONS COMPRISING LP(A) INHIBITOR COMPOUNDS2025-11-1319388561Docketed New Case - Ready for Examination
TRKA RNA INTERFERENCE AGENTS AND USES THEREOF2025-11-12PCTUS2025055151RO PROCESSING COMPLETED-PLACED IN STORAGE
PRIME DOSE SETTING ASSEMBLY FOR INJECTION DEVICE2025-11-06PCTUS2025054310RO PROCESSING COMPLETED-PLACED IN STORAGE
MEDICATION DELIVERY DEVICE WITH MEDICATION CARTRIDGE AND NEEDLE ASSEMBLY2025-11-06PCTUS2025054303RO PROCESSING COMPLETED-PLACED IN STORAGE
GIP/GLP1 AGONIST COMPOSITIONS2025-11-0419379195Patented Caseparent 12453756
ALK7 RNA INTERFERENCE AGENTS2025-10-3163909146Application Dispatched from Preexam, Not Yet Docketed
WASH AFTER DEBLOCK IN SOLID PHASE OLIGONUCLEOTIDE SYNTHESIS2025-10-23PCTUS2025052206RO PROCESSING COMPLETED-PLACED IN STORAGE
SYSTEMS AND METHODS FOR PERFORMING SOLID PHASE OLIGONUCLEOTIDE SYNTHESIS2025-10-23PCTUS2025052176RO PROCESSING COMPLETED-PLACED IN STORAGE
DETRITYLATION STEP IN SOLID PHASE OLIGONUCLEOTIDE SYNTHESIS2025-10-23PCTUS2025052196RO PROCESSING COMPLETED-PLACED IN STORAGE
CAPPING STEP2025-10-23PCTUS2025052232RO PROCESSING COMPLETED-PLACED IN STORAGE
OXIDATION/ SULFURIZATION STEP AND WASH AFTER OXIDATION/SULFURIZATION2025-10-23PCTUS2025052225RO PROCESSING COMPLETED-PLACED IN STORAGE
TRKA RNA INTERFERENCE AGENTS AND USES THEREOF2025-10-1763901113Application Dispatched from Preexam, Not Yet Docketed
SYSTEMS AND METHODS FOR REMOTE PRESCRIPTION OF MEDICATION-DOSING REGIMENS2025-10-1019355120Docketed New Case - Ready for Examination
ANTI-UNC5C ANTIBODIES2025-10-0919353681Docketed New Case - Ready for Examination
SOD1 RNA INTERFERENCE AGENTS2025-10-09PCTUS2025050166RO PROCESSING COMPLETED-PLACED IN STORAGE
NPR-C MEDIATED DELIVERY TO ADIPOSE TISSUE2025-10-06PCTUS2025049575RO PROCESSING COMPLETED-PLACED IN STORAGE
REAGENTS AND METHODS FOR IMAGING CANCERS EXPRESSING PDGFRALPHA2025-10-0219472083Application Undergoing Preexam Processing
SYSTEMS AND METHODS FOR TESTING IDENTIFICATION DEVICES FOR MEDICATION DELIVERY DEVICES2025-10-02PCTUS2025049215RO PROCESSING COMPLETED-PLACED IN STORAGE
ANTI-CD137 ANTIBODIES2025-09-3019346308Application Undergoing Preexam Processingparent 12453771
KRAS INHIBITORS2025-09-3019344841Patented Case
PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST2025-09-2619341996Response to Non-Final Office Action Entered and Forwarded to Examiner
TIRZEPATIDE BINDING MOLECULES, AND USES THEREOF2025-09-24PCTUS2025047637RO PROCESSING COMPLETED-PLACED IN STORAGE
ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS2025-09-2419168359Application Undergoing Preexam Processing
PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST2025-09-2419338984Response to Non-Final Office Action Entered and Forwarded to Examiner
CONJUGATES COMPRISING BIS-MSPT LINKER2025-09-19PCTUS2025047055RO PROCESSING COMPLETED-PLACED IN STORAGE
CONJUGATES COMPRISING BIS-MSPT LINKER2025-09-1919333454Docketed New Case - Ready for Examination
IMPROVED CHEMICAL METHODS FOR MANUFACTURING A PHOSPHORAMIDITE USED IN RNA SYNTHESIS2025-09-18PCTUS2025046904RO PROCESSING COMPLETED-PLACED IN STORAGE
PAN-ELR+ CXC CHEMOKINE ANTIBODIES AND IL-23P19 ANTIBODIES FOR THE TREATMENT OF ULCERATIVE COLITIS2025-09-12PCTUS2025046081RO PROCESSING COMPLETED-PLACED IN STORAGE
STABLE APO ACTIVE FUSION OF A G PROTEIN COUPLED RECEPTOR (GPCR) AND A G PROTEIN ALPHA SUBUNIT HELIX 52025-09-11PCTUS2025045854RO PROCESSING COMPLETED-PLACED IN STORAGE
SYRINGE SYSTEMS AND METHODS FOR DISPENSING DRUG PRODUCTS2025-09-10PCTUS2025045747RO PROCESSING COMPLETED-PLACED IN STORAGE
KRAS INHIBITORS2025-09-10PCTUS2025045670RO PROCESSING COMPLETED-PLACED IN STORAGE
COMPOUNDS AND METHODS TARGETING INTERLEUKIN-192025-09-0919323384Docketed New Case - Ready for Examinationparent 12459997
DISSOLVING MICRONEEDLE PATCH FOR TRANSDERMAL DELIVERY OF A PEPTIDE2025-09-08PCTUS2025045322RO PROCESSING COMPLETED-PLACED IN STORAGE
METHOD OF TREATING ALZHEIMER'S DISEASE USING ANTI-N3PGLU AMYLOID BETA ANTIBODIES2025-09-08PCTUS2025045352RO PROCESSING COMPLETED-PLACED IN STORAGE
ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY-DRUG CONJUGATES, ANTI-VEGFR-2 ANTIBODIES AND ANTI-PD1/PD-L1 ANTIBODIES2025-09-0519162616Sent to Classification contractor
PLIN1 RNA INTERFERENCE AGENTS2025-09-0363875101Application Dispatched from Preexam, Not Yet Docketed
NPR-C MEDIATED DELIVERY TO ADIPOSE TISSUE2025-08-2163867907Application Dispatched from Preexam, Not Yet Docketed
ENGINEERED REGULATORY SPLICE ELEMENTS FOR GENE THERAPIES2025-08-18PCTUS2025042340RO PROCESSING COMPLETED-PLACED IN STORAGE

How to read this

Every row here is an application — a request the USPTO has not yet decided. In plain English: these filings show where Eli Lilly and Company’s R&D effort is pointed right now, often 18–24 months before any product ships — but an application can be amended, abandoned, or rejected, and most confer no enforceable rights until granted. A “granted parent” tag means the filing continues a patent family that already has a grant — the new claims themselves are still pending. Filings are matched by applicant name, so work filed under subsidiary or research-entity names may not appear. Source: USPTO Open Data Portal (public).